Zenas BioPharma Inc (ZBIO) Stock Price, Quote, News & History

ZBIONASDAQ
$33.05
0.501.54%
At close: Sep 21, 5:00 PM EST
$33.05
0.501.54%
Pre-Market: 7:00 AM EST

Zenas BioPharma (ZBIO) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-225.97M
Investing Cash Flow (TTM)
-309.41M
Financing Cash Flow (TTM)
689.00M
Free Cash Flow (TTM)
-290.97M
Capital Expenditure (TTM)
-65.00M
Net Change in Cash (TTM)
153.61M

Analyst Trends and Forecast

1
1
May
2
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.81B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
1770.65
PB Ratio (TTM)
8.73
Earnings Yield % (TTM)
-29.10%
Earnings Yield % (FWD)
-15.44%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.79

Company Debt

Total Debt
$297.02M
LT Debt
$297.02M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$196.58M
Debt to Equity
1.21
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$33.05
Volume / Avg.
3.00 / 837.53K
Day Range
- - -
52 Wk Range
13.50 - 44.60
Market Cap
$2.15B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
57
Short Interest
26.36%
Days to Cover
14.18

About

Sector
Health Care
Industry
Biotechnology
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the a...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Zenas BioPharma (ZBIO) stock?

A

You can purchase shares of Zenas BioPharma (NASDAQ:ZBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zenas BioPharma (ZBIO) competitors?

Q

What is the forecast, or price target, for Zenas BioPharma (ZBIO) stock?

A

Zenas BioPharma has a consensus price target of $40.00.

Q

What is the current price for Zenas BioPharma (ZBIO)?

A

The stock price for Zenas BioPharma (NASDAQ: ZBIO) is $33.05 last updated September 22, 2026 at 4:00 PM EDT.

Q

Does Zenas BioPharma (ZBIO) pay a dividend?

A

There are no upcoming dividends for Zenas BioPharma.

Q

When is Zenas BioPharma (NASDAQ:ZBIO) reporting earnings?

A

Zenas BioPharma does not have any upcoming earnings scheduled.

Q

Is Zenas BioPharma (ZBIO) going to split?

A

There is no upcoming split for Zenas BioPharma.

Q

What sector and industry does Zenas BioPharma (ZBIO) operate in?

A

Zenas BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.